NYSE American - Delayed Quote USD
Cybin Inc. (CYBN)
8.58
+0.26
+(3.12%)
At close: 4:00:00 PM EDT
8.70
+0.12
+(1.40%)
After hours: 7:17:38 PM EDT
Research Analysis
Earnings Estimate
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -1.2 | -1.22 | -3.85 | -4.64 |
| Low Estimate | -1.47 | -1.48 | -5.52 | -5.69 |
| High Estimate | -0.72 | -0.76 | -0.55 | -3.59 |
| Year Ago EPS | -0.76 | -0.76 | -9.5 | -3.85 |
Revenue Estimate
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in CAD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -1.52 | -1.33 | -0.91 | -1.57 |
| EPS Actual | -0.76 | -0.76 | -2.86 | -0.53 |
| Difference | 0.76 | 0.57 | -1.95 | 1.04 |
| Surprise % | 50.00% | 42.86% | -215.15% | 66.19% |
EPS Trend
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.2 | -1.22 | -3.85 | -4.64 |
| 7 Days Ago | -1.22 | -1.24 | -3.85 | -5.16 |
| 30 Days Ago | -1.22 | -1.24 | -3.85 | -5.16 |
| 60 Days Ago | -1.22 | -1.24 | -3.85 | -5.16 |
| 90 Days Ago | -1.19 | -1.47 | -4.95 | -5.98 |
EPS Revisions
| Currency in CAD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| CYBN | -57.57% | -59.87% | 59.50% | -20.60% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Upgrades & Downgrades
| Initiated | Guggenheim: Buy | 3/13/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/13/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 2/12/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 1/27/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 11/19/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/19/2024 |
Related Tickers
ATAI Atai Life Sciences N.V.
2.4700
+5.11%
MNMD Mind Medicine (MindMed) Inc.
7.65
-0.52%
GHRS GH Research PLC
12.43
+2.90%
CMND Clearmind Medicine Inc.
0.9041
-4.18%
DRUG Bright Minds Biosciences Inc.
27.55
+0.33%
NRXP NRx Pharmaceuticals, Inc.
2.9500
+8.46%
IMTX Immatics N.V.
5.75
-2.21%
JSPR Jasper Therapeutics, Inc.
6.00
+1.69%
VSTM Verastem, Inc.
6.17
+4.66%
VTYX Ventyx Biosciences, Inc.
1.9900
+0.25%